These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

779 related items for PubMed ID: 10380358

  • 1. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
    Bajusz S, Fauszt I, Németh K, Barabás E, Juhász A, Patthy M, Bauer PI.
    Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
    [Abstract] [Full Text] [Related]

  • 2. Peptidyl beta-homo-aspartals: specific inhibitors of interleukin-1 beta converting enzyme and its homologues (caspases).
    Bajusz S, Fauszt I, Németh K, Barabás E, Juhász A, Patthy M.
    Bioorg Med Chem Lett; 1998 Jun 16; 8(12):1477-82. PubMed ID: 9873373
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8.
    James KE, Asgian JL, Li ZZ, Ekici OD, Rubin JR, Mikolajczyk J, Salvesen GS, Powers JC.
    J Med Chem; 2004 Mar 11; 47(6):1553-74. PubMed ID: 14998341
    [Abstract] [Full Text] [Related]

  • 4. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis.
    Nicholson DW.
    Nat Biotechnol; 1996 Mar 11; 14(3):297-301. PubMed ID: 9630889
    [Abstract] [Full Text] [Related]

  • 5. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.
    Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA.
    Nature; 1995 Jul 06; 376(6535):37-43. PubMed ID: 7596430
    [Abstract] [Full Text] [Related]

  • 6. Role of interleukin-1 beta converting enzyme (ICE) in leukemia.
    Estrov Z, Talpaz M.
    Cytokines Mol Ther; 1996 Mar 06; 2(1):1-11. PubMed ID: 9384684
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo studies of ICE inhibitors.
    Livingston DJ.
    J Cell Biochem; 1997 Jan 06; 64(1):19-26. PubMed ID: 9015750
    [Abstract] [Full Text] [Related]

  • 8. IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha.
    Howard AD, Kostura MJ, Thornberry N, Ding GJ, Limjuco G, Weidner J, Salley JP, Hogquist KA, Chaplin DD, Mumford RA.
    J Immunol; 1991 Nov 01; 147(9):2964-9. PubMed ID: 1919001
    [Abstract] [Full Text] [Related]

  • 9. Ionizing radiation-induced, Bax-mediated cell death is dependent on activation of cysteine and serine proteases.
    Gong B, Chen Q, Endlich B, Mazumder S, Almasan A.
    Cell Growth Differ; 1999 Jul 01; 10(7):491-502. PubMed ID: 10437917
    [Abstract] [Full Text] [Related]

  • 10. Inactivation of cysteine proteases.
    Govardhan CP, Abeles RH.
    Arch Biochem Biophys; 1996 Jun 01; 330(1):110-4. PubMed ID: 8651683
    [Abstract] [Full Text] [Related]

  • 11. Identification and mapping of Casp7, a cysteine protease resembling CPP32 beta, interleukin-1 beta converting enzyme, and CED-3.
    Juan TS, McNiece IK, Argento JM, Jenkins NA, Gilbert DJ, Copeland NG, Fletcher FA.
    Genomics; 1997 Feb 15; 40(1):86-93. PubMed ID: 9070923
    [Abstract] [Full Text] [Related]

  • 12. Organic azide inhibitors of cysteine proteases.
    Le GT, Abbenante G, Madala PK, Hoang HN, Fairlie DP.
    J Am Chem Soc; 2006 Sep 27; 128(38):12396-7. PubMed ID: 16984172
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks.
    Schirmeister T.
    Biopolymers; 1999 Sep 27; 51(1):87-97. PubMed ID: 10380356
    [Abstract] [Full Text] [Related]

  • 14. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T.
    J Med Chem; 1999 Feb 25; 42(4):560-72. PubMed ID: 10052963
    [Abstract] [Full Text] [Related]

  • 15. The inhibitor profiling of the caspase family of proteases using substrate-derived peptide glyoxals.
    Murphy DJ, Walker B, Ryan CA, Martin SL.
    Biochem Biophys Res Commun; 2010 Nov 19; 402(3):483-8. PubMed ID: 20955686
    [Abstract] [Full Text] [Related]

  • 16. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
    Malikayil JA, Burkhart JP, Schreuder HA, Broersma RJ, Tardif C, Kutcher LW, Mehdi S, Schatzman GL, Neises B, Peet NP.
    Biochemistry; 1997 Feb 04; 36(5):1034-40. PubMed ID: 9033393
    [Abstract] [Full Text] [Related]

  • 17. [Involvement of ICE/CED 3 family proteases in antitumor agent-induced apoptosis].
    Mashima T, Tsuruo T.
    Gan To Kagaku Ryoho; 1997 Jan 04; 24(2):211-5. PubMed ID: 9030233
    [Abstract] [Full Text] [Related]

  • 18. [ICE family proteins].
    Mashima T, Tsuruo T.
    Gan To Kagaku Ryoho; 1997 Sep 04; 24(11):1454-9. PubMed ID: 9309141
    [Abstract] [Full Text] [Related]

  • 19. Evidence that non-caspase proteases are required for chromatin degradation during apoptosis.
    Hughes FM, Evans-Storms RB, Cidlowski JA.
    Cell Death Differ; 1998 Dec 04; 5(12):1017-27. PubMed ID: 9894608
    [Abstract] [Full Text] [Related]

  • 20. Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex.
    Blanchard H, Donepudi M, Tschopp M, Kodandapani L, Wu JC, Grütter MG.
    J Mol Biol; 2000 Sep 08; 302(1):9-16. PubMed ID: 10964557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.